APO Research
Talk to an analyst

APO RESEARCH · REPORT

Human Single-Cell Multi-Omics

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Human Single-Cell Multi-Omics Market Analysis and Forecast 2026-2032

1 January 2026193 pages

Choose your research edition.

Industry ResearchHuman Single-Cell Multi-Omics Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Human Single-Cell Multi-Omics Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Human Single-Cell Multi-Omics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Human Single-Cell Multi-Omics Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Human Single-Cell Multi-Omics Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Human Single-Cell Multi-Omics market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Human Single-Cell Multi-Omics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Human Single-Cell Multi-Omics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Human Single-Cell Multi-Omics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Human Single-Cell Multi-Omics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Human Single-Cell Multi-Omics include 10x Genomics, 1CellBio, BGI Genomics, Bio-Rad Laboratories, Celsee, Fluidigm Corporation, Fluxion Biosciences, MissionBio and NanoString Technologies, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Human Single-Cell Multi-Omics, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Human Single-Cell Multi-Omics, also provides the revenue of main regions and countries. Of the upcoming market potential for Human Single-Cell Multi-Omics, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Human Single-Cell Multi-Omics revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Human Single-Cell Multi-Omics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Human Single-Cell Multi-Omics revenue, projected growth trends, production technology, application and end-user industry.

Human Single-Cell Multi-Omics Segment by Company

10x Genomics

1CellBio

BGI Genomics

Bio-Rad Laboratories

Celsee

Fluidigm Corporation

Fluxion Biosciences

MissionBio

NanoString Technologies

Takara Bio

Human Single-Cell Multi-Omics Segment by Type

Single-Cell Proteomics

Single-Cell Genomics

Single-Cell Transcriptomics

Human Single-Cell Multi-Omics Segment by Application

Synthetic Biology

Clinical Research

Translational Research

Human Single-Cell Multi-Omics Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Single-Cell Multi-Omics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Human Single-Cell Multi-Omics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Single-Cell Multi-Omics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Human Single-Cell Multi-Omics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Human Single-Cell Multi-Omics company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Human Single-Cell Multi-Omics revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Human Single-Cell Multi-Omics Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Single-Cell Proteomics Major Player Table 3. Single-Cell Genomics Major Player Table 4. Single-Cell Transcriptomics Major Player Table 5. Global Human Single-Cell Multi-Omics Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Synthetic Biology Major Player Table 7. Clinical Research Major Player Table 8. Translational Research Major Player Table 9. Human Single-Cell Multi-Omics Industry Trends Table 10. Human Single-Cell Multi-Omics Industry Drivers Table 11. Human Single-Cell Multi-Omics Industry Opportunities and Challenges Table 12. Human Single-Cell Multi-Omics Industry Restraints Table 13. Global Human Single-Cell Multi-Omics Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Human Single-Cell Multi-Omics Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Human Single-Cell Multi-Omics Market Share by Region (2021-2026) Table 16. Global Human Single-Cell Multi-Omics Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Human Single-Cell Multi-Omics Market Share by Region (2027-2032) Table 18. Global Human Single-Cell Multi-Omics Revenue by Players (US$ Million) & (2021-2026) Table 19. Global Human Single-Cell Multi-Omics Revenue Market Share by Players (2021-2026) Table 20. Global Human Single-Cell Multi-Omics Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global Human Single-Cell Multi-Omics Key Players Headquarters & Area Served Table 22. Global Human Single-Cell Multi-Omics Players, Product Type & Application Table 23. Global Human Single-Cell Multi-Omics Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global Human Single-Cell Multi-Omics by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global Human Single-Cell Multi-Omics Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Human Single-Cell Multi-Omics Revenue by Type (2021-2026) & (US$ Million) Table 28. Global Human Single-Cell Multi-Omics Revenue by Type (2027-2032) & (US$ Million) Table 29. Global Human Single-Cell Multi-Omics Revenue Market Share by Type (2021-2026) Table 30. Global Human Single-Cell Multi-Omics Revenue Market Share by Type (2027-2032) Table 31. Global Human Single-Cell Multi-Omics Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Human Single-Cell Multi-Omics Revenue by Application (2021-2026) & (US$ Million) Table 33. Global Human Single-Cell Multi-Omics Revenue by Application (2027-2032) & (US$ Million) Table 34. Global Human Single-Cell Multi-Omics Revenue Market Share by Application (2021-2026) Table 35. Global Human Single-Cell Multi-Omics Revenue Market Share by Application (2027-2032) Table 36. 10x Genomics Company Information Table 37. 10x Genomics Business Overview Table 38. 10x Genomics Human Single-Cell Multi-Omics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. 10x Genomics Human Single-Cell Multi-Omics Product Portfolio Table 40. 10x Genomics Recent Development Table 41. 1CellBio Company Information Table 42. 1CellBio Business Overview Table 43. 1CellBio Human Single-Cell Multi-Omics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. 1CellBio Human Single-Cell Multi-Omics Product Portfolio Table 45. 1CellBio Recent Development Table 46. BGI Genomics Company Information Table 47. BGI Genomics Business Overview Table 48. BGI Genomics Human Single-Cell Multi-Omics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. BGI Genomics Human Single-Cell Multi-Omics Product Portfolio Table 50. BGI Genomics Recent Development Table 51. Bio-Rad Laboratories Company Information Table 52. Bio-Rad Laboratories Business Overview Table 53. Bio-Rad Laboratories Human Single-Cell Multi-Omics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Bio-Rad Laboratories Human Single-Cell Multi-Omics Product Portfolio Table 55. Bio-Rad Laboratories Recent Development Table 56. Celsee Company Information Table 57. Celsee Business Overview Table 58. Celsee Human Single-Cell Multi-Omics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Celsee Human Single-Cell Multi-Omics Product Portfolio Table 60. Celsee Recent Development Table 61. Fluidigm Corporation Company Information Table 62. Fluidigm Corporation Business Overview Table 63. Fluidigm Corporation Human Single-Cell Multi-Omics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Fluidigm Corporation Human Single-Cell Multi-Omics Product Portfolio Table 65. Fluidigm Corporation Recent Development Table 66. Fluxion Biosciences Company Information Table 67. Fluxion Biosciences Business Overview Table 68. Fluxion Biosciences Human Single-Cell Multi-Omics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Fluxion Biosciences Human Single-Cell Multi-Omics Product Portfolio Table 70. Fluxion Biosciences Recent Development Table 71. MissionBio Company Information Table 72. MissionBio Business Overview Table 73. MissionBio Human Single-Cell Multi-Omics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. MissionBio Human Single-Cell Multi-Omics Product Portfolio Table 75. MissionBio Recent Development Table 76. NanoString Technologies Company Information Table 77. NanoString Technologies Business Overview Table 78. NanoString Technologies Human Single-Cell Multi-Omics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. NanoString Technologies Human Single-Cell Multi-Omics Product Portfolio Table 80. NanoString Technologies Recent Development Table 81. Takara Bio Company Information Table 82. Takara Bio Business Overview Table 83. Takara Bio Human Single-Cell Multi-Omics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Takara Bio Human Single-Cell Multi-Omics Product Portfolio Table 85. Takara Bio Recent Development Table 86. North America Human Single-Cell Multi-Omics Revenue by Type (2021-2026) & (US$ Million) Table 87. North America Human Single-Cell Multi-Omics Revenue by Type (2027-2032) & (US$ Million) Table 88. North America Human Single-Cell Multi-Omics Revenue by Application (2021-2026) & (US$ Million) Table 89. North America Human Single-Cell Multi-Omics Revenue by Application (2027-2032) & (US$ Million) Table 90. North America Human Single-Cell Multi-Omics Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 91. North America Human Single-Cell Multi-Omics Revenue by Country (2021-2026) & (US$ Million) Table 92. North America Human Single-Cell Multi-Omics Revenue by Country (US$ Million) & (2027-2032) Table 93. Europe Human Single-Cell Multi-Omics Revenue by Type (2021-2026) & (US$ Million) Table 94. Europe Human Single-Cell Multi-Omics Revenue by Type (2027-2032) & (US$ Million) Table 95. Europe Human Single-Cell Multi-Omics Revenue by Application (2021-2026) & (US$ Million) Table 96. Europe Human Single-Cell Multi-Omics Revenue by Application (2027-2032) & (US$ Million) Table 97. Europe Human Single-Cell Multi-Omics Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 98. Europe Human Single-Cell Multi-Omics Revenue by Country (2021-2026) & (US$ Million) Table 99. Europe Human Single-Cell Multi-Omics Revenue by Country (US$ Million) & (2027-2032) Table 100. China Human Single-Cell Multi-Omics Revenue by Type (2021-2026) & (US$ Million) Table 101. China Human Single-Cell Multi-Omics Revenue by Type (2027-2032) & (US$ Million) Table 102. China Human Single-Cell Multi-Omics Revenue by Application (2021-2026) & (US$ Million) Table 103. China Human Single-Cell Multi-Omics Revenue by Application (2027-2032) & (US$ Million) Table 104. Asia Human Single-Cell Multi-Omics Revenue by Type (2021-2026) & (US$ Million) Table 105. Asia Human Single-Cell Multi-Omics Revenue by Type (2027-2032) & (US$ Million) Table 106. Asia Human Single-Cell Multi-Omics Revenue by Application (2021-2026) & (US$ Million) Table 107. Asia Human Single-Cell Multi-Omics Revenue by Application (2027-2032) & (US$ Million) Table 108. Asia Human Single-Cell Multi-Omics Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 109. Asia Human Single-Cell Multi-Omics Revenue by Region (US$ Million) & (2021-2026) Table 110. Asia Human Single-Cell Multi-Omics Revenue by Region (US$ Million) & (2027-2032) Table 111. SAMEA Human Single-Cell Multi-Omics Revenue by Type (2021-2026) & (US$ Million) Table 112. SAMEA Human Single-Cell Multi-Omics Revenue by Type (2027-2032) & (US$ Million) Table 113. SAMEA Human Single-Cell Multi-Omics Revenue by Application (2021-2026) & (US$ Million) Table 114. SAMEA Human Single-Cell Multi-Omics Revenue by Application (2027-2032) & (US$ Million) Table 115. SAMEA Human Single-Cell Multi-Omics Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 116. SAMEA Human Single-Cell Multi-Omics Revenue by Country (2021-2026) & (US$ Million) Table 117. SAMEA Human Single-Cell Multi-Omics Revenue by Country (US$ Million) & (2027-2032) Table 118. Research Programs/Design for This Report Table 119. Authors List of This Report Table 120. Secondary Sources Table 121. Primary Sources List of Figures Figure 1. Human Single-Cell Multi-Omics Image Figure 2. Global Human Single-Cell Multi-Omics Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Human Single-Cell Multi-Omics Market Size Share 2021 VS 2025 VS 2032 Figure 4. Single-Cell Proteomics Image Figure 5. Single-Cell Genomics Image Figure 6. Single-Cell Transcriptomics Image Figure 7. Global Human Single-Cell Multi-Omics Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Human Single-Cell Multi-Omics Market Size Share 2021 VS 2025 VS 2032 Figure 9. Synthetic Biology Image Figure 10. Clinical Research Image Figure 11. Translational Research Image Figure 12. Global Human Single-Cell Multi-Omics Market Size (US$ Million) & (2021-2032) Figure 13. Global Human Single-Cell Multi-Omics Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Human Single-Cell Multi-Omics Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global Human Single-Cell Multi-Omics Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Human Single-Cell Multi-Omics Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Human Single-Cell Multi-Omics Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Human Single-Cell Multi-Omics Revenue Market Share by Type (2021-2032) Figure 20. Global Human Single-Cell Multi-Omics Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Human Single-Cell Multi-Omics Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global Human Single-Cell Multi-Omics Revenue Market Share by Application (2021-2032) Figure 23. North America Human Single-Cell Multi-Omics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America Human Single-Cell Multi-Omics Revenue Share by Type (2021-2032) Figure 25. North America Human Single-Cell Multi-Omics Revenue Share by Application (2021-2032) Figure 26. North America Human Single-Cell Multi-Omics Revenue Share by Country (2021-2032) Figure 27. United States Human Single-Cell Multi-Omics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada Human Single-Cell Multi-Omics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico Human Single-Cell Multi-Omics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe Human Single-Cell Multi-Omics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe Human Single-Cell Multi-Omics Revenue Share by Type (2021-2032) Figure 32. Europe Human Single-Cell Multi-Omics Revenue Share by Application (2021-2032) Figure 33. Europe Human Single-Cell Multi-Omics Revenue Share by Country (2021-2032) Figure 34. Germany Human Single-Cell Multi-Omics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France Human Single-Cell Multi-Omics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. Human Single-Cell Multi-Omics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy Human Single-Cell Multi-Omics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain Human Single-Cell Multi-Omics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia Human Single-Cell Multi-Omics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands Human Single-Cell Multi-Omics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries Human Single-Cell Multi-Omics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China Human Single-Cell Multi-Omics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China Human Single-Cell Multi-Omics Revenue Share by Type (2021-2032) Figure 44. China Human Single-Cell Multi-Omics Revenue Share by Application (2021-2032) Figure 45. Asia Human Single-Cell Multi-Omics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia Human Single-Cell Multi-Omics Revenue Share by Type (2021-2032) Figure 47. Asia Human Single-Cell Multi-Omics Revenue Share by Application (2021-2032) Figure 48. Asia Human Single-Cell Multi-Omics Revenue Share by Region (2021-2032) Figure 49. Japan Human Single-Cell Multi-Omics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea Human Single-Cell Multi-Omics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India Human Single-Cell Multi-Omics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia Human Single-Cell Multi-Omics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan Human Single-Cell Multi-Omics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia Human Single-Cell Multi-Omics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA Human Single-Cell Multi-Omics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA Human Single-Cell Multi-Omics Revenue Share by Type (2021-2032) Figure 57. SAMEA Human Single-Cell Multi-Omics Revenue Share by Application (2021-2032) Figure 58. SAMEA Human Single-Cell Multi-Omics Revenue Share by Country (2021-2032) Figure 59. Brazil Human Single-Cell Multi-Omics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina Human Single-Cell Multi-Omics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile Human Single-Cell Multi-Omics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia Human Single-Cell Multi-Omics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru Human Single-Cell Multi-Omics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia Human Single-Cell Multi-Omics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel Human Single-Cell Multi-Omics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE Human Single-Cell Multi-Omics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey Human Single-Cell Multi-Omics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran Human Single-Cell Multi-Omics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt Human Single-Cell Multi-Omics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Single-Cell Proteomics
  • Single-Cell Genomics
  • Single-Cell Transcriptomics
Applications
  • Synthetic Biology
  • Clinical Research
  • Translational Research
Companies covered
  • 10x Genomics
  • 1CellBio
  • BGI Genomics
  • Bio-Rad Laboratories
  • Celsee
  • Fluidigm Corporation
  • Fluxion Biosciences
  • MissionBio
  • NanoString Technologies
  • Takara Bio

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Human Single-Cell Multi-Omics Market by Type
  3. 1.2.1 Global Human Single-Cell Multi-Omics Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Single-Cell Proteomics
  5. 1.2.3 Single-Cell Genomics
  6. 1.2.4 Single-Cell Transcriptomics
  7. 1.3 Human Single-Cell Multi-Omics Market by Application
  8. 1.3.1 Global Human Single-Cell Multi-Omics Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Synthetic Biology
  10. 1.3.3 Clinical Research
  11. 1.3.4 Translational Research
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Human Single-Cell Multi-Omics Market Dynamics
  1. 2.1 Human Single-Cell Multi-Omics Industry Trends
  2. 2.2 Human Single-Cell Multi-Omics Industry Drivers
  3. 2.3 Human Single-Cell Multi-Omics Industry Opportunities and Challenges
  4. 2.4 Human Single-Cell Multi-Omics Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Human Single-Cell Multi-Omics Market Perspective (2021-2032)
  2. 3.2 Global Human Single-Cell Multi-Omics Growth Trends by Region
  3. 3.2.1 Global Human Single-Cell Multi-Omics Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Human Single-Cell Multi-Omics Market Size by Region (2021-2026)
  5. 3.2.3 Global Human Single-Cell Multi-Omics Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Human Single-Cell Multi-Omics Revenue by Players
  2. 4.1.1 Global Human Single-Cell Multi-Omics Revenue by Players (2021-2026)
  3. 4.1.2 Global Human Single-Cell Multi-Omics Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Human Single-Cell Multi-Omics Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Human Single-Cell Multi-Omics Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Human Single-Cell Multi-Omics Key Players Headquarters & Area Served
  7. 4.4 Global Human Single-Cell Multi-Omics Players, Product Type & Application
  8. 4.5 Global Human Single-Cell Multi-Omics Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Human Single-Cell Multi-Omics Market CR5 and HHI
  11. 4.6.3 2025 Human Single-Cell Multi-Omics Tier 1, Tier 2, and Tier 3
5 Human Single-Cell Multi-Omics Market Size by Type
  1. 5.1 Global Human Single-Cell Multi-Omics Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Human Single-Cell Multi-Omics Revenue by Type (2021-2032)
  3. 5.3 Global Human Single-Cell Multi-Omics Revenue Market Share by Type (2021-2032)
6 Human Single-Cell Multi-Omics Market Size by Application
  1. 6.1 Global Human Single-Cell Multi-Omics Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Human Single-Cell Multi-Omics Revenue by Application (2021-2032)
  3. 6.3 Global Human Single-Cell Multi-Omics Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 10x Genomics
  2. 7.1.1 10x Genomics Company Information
  3. 7.1.2 10x Genomics Business Overview
  4. 7.1.3 10x Genomics Human Single-Cell Multi-Omics Revenue and Gross Margin (2021-2026)
  5. 7.1.4 10x Genomics Human Single-Cell Multi-Omics Product Portfolio
  6. 7.1.5 10x Genomics Recent Developments
  7. 7.2 1CellBio
  8. 7.2.1 1CellBio Company Information
  9. 7.2.2 1CellBio Business Overview
  10. 7.2.3 1CellBio Human Single-Cell Multi-Omics Revenue and Gross Margin (2021-2026)
  11. 7.2.4 1CellBio Human Single-Cell Multi-Omics Product Portfolio
  12. 7.2.5 1CellBio Recent Developments
  13. 7.3 BGI Genomics
  14. 7.3.1 BGI Genomics Company Information
  15. 7.3.2 BGI Genomics Business Overview
  16. 7.3.3 BGI Genomics Human Single-Cell Multi-Omics Revenue and Gross Margin (2021-2026)
  17. 7.3.4 BGI Genomics Human Single-Cell Multi-Omics Product Portfolio
  18. 7.3.5 BGI Genomics Recent Developments
  19. 7.4 Bio-Rad Laboratories
  20. 7.4.1 Bio-Rad Laboratories Company Information
  21. 7.4.2 Bio-Rad Laboratories Business Overview
  22. 7.4.3 Bio-Rad Laboratories Human Single-Cell Multi-Omics Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Bio-Rad Laboratories Human Single-Cell Multi-Omics Product Portfolio
  24. 7.4.5 Bio-Rad Laboratories Recent Developments
  25. 7.5 Celsee
  26. 7.5.1 Celsee Company Information
  27. 7.5.2 Celsee Business Overview
  28. 7.5.3 Celsee Human Single-Cell Multi-Omics Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Celsee Human Single-Cell Multi-Omics Product Portfolio
  30. 7.5.5 Celsee Recent Developments
  31. 7.6 Fluidigm Corporation
  32. 7.6.1 Fluidigm Corporation Company Information
  33. 7.6.2 Fluidigm Corporation Business Overview
  34. 7.6.3 Fluidigm Corporation Human Single-Cell Multi-Omics Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Fluidigm Corporation Human Single-Cell Multi-Omics Product Portfolio
  36. 7.6.5 Fluidigm Corporation Recent Developments
  37. 7.7 Fluxion Biosciences
  38. 7.7.1 Fluxion Biosciences Company Information
  39. 7.7.2 Fluxion Biosciences Business Overview
  40. 7.7.3 Fluxion Biosciences Human Single-Cell Multi-Omics Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Fluxion Biosciences Human Single-Cell Multi-Omics Product Portfolio
  42. 7.7.5 Fluxion Biosciences Recent Developments
  43. 7.8 MissionBio
  44. 7.8.1 MissionBio Company Information
  45. 7.8.2 MissionBio Business Overview
  46. 7.8.3 MissionBio Human Single-Cell Multi-Omics Revenue and Gross Margin (2021-2026)
  47. 7.8.4 MissionBio Human Single-Cell Multi-Omics Product Portfolio
  48. 7.8.5 MissionBio Recent Developments
  49. 7.9 NanoString Technologies
  50. 7.9.1 NanoString Technologies Company Information
  51. 7.9.2 NanoString Technologies Business Overview
  52. 7.9.3 NanoString Technologies Human Single-Cell Multi-Omics Revenue and Gross Margin (2021-2026)
  53. 7.9.4 NanoString Technologies Human Single-Cell Multi-Omics Product Portfolio
  54. 7.9.5 NanoString Technologies Recent Developments
  55. 7.10 Takara Bio
  56. 7.10.1 Takara Bio Company Information
  57. 7.10.2 Takara Bio Business Overview
  58. 7.10.3 Takara Bio Human Single-Cell Multi-Omics Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Takara Bio Human Single-Cell Multi-Omics Product Portfolio
  60. 7.10.5 Takara Bio Recent Developments
8 North America
  1. 8.1 North America Human Single-Cell Multi-Omics Revenue (2021-2032)
  2. 8.2 North America Human Single-Cell Multi-Omics Revenue by Type (2021-2032)
  3. 8.2.1 North America Human Single-Cell Multi-Omics Revenue by Type (2021-2026)
  4. 8.2.2 North America Human Single-Cell Multi-Omics Revenue by Type (2027-2032)
  5. 8.3 North America Human Single-Cell Multi-Omics Revenue Share by Type (2021-2032)
  6. 8.4 North America Human Single-Cell Multi-Omics Revenue by Application (2021-2032)
  7. 8.4.1 North America Human Single-Cell Multi-Omics Revenue by Application (2021-2026)
  8. 8.4.2 North America Human Single-Cell Multi-Omics Revenue by Application (2027-2032)
  9. 8.5 North America Human Single-Cell Multi-Omics Revenue Share by Application (2021-2032)
  10. 8.6 North America Human Single-Cell Multi-Omics Revenue by Country
  11. 8.6.1 North America Human Single-Cell Multi-Omics Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Human Single-Cell Multi-Omics Revenue by Country (2021-2026)
  13. 8.6.3 North America Human Single-Cell Multi-Omics Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
9 Europe
  1. 9.1 Europe Human Single-Cell Multi-Omics Revenue (2021-2032)
  2. 9.2 Europe Human Single-Cell Multi-Omics Revenue by Type (2021-2032)
  3. 9.2.1 Europe Human Single-Cell Multi-Omics Revenue by Type (2021-2026)
  4. 9.2.2 Europe Human Single-Cell Multi-Omics Revenue by Type (2027-2032)
  5. 9.3 Europe Human Single-Cell Multi-Omics Revenue Share by Type (2021-2032)
  6. 9.4 Europe Human Single-Cell Multi-Omics Revenue by Application (2021-2032)
  7. 9.4.1 Europe Human Single-Cell Multi-Omics Revenue by Application (2021-2026)
  8. 9.4.2 Europe Human Single-Cell Multi-Omics Revenue by Application (2027-2032)
  9. 9.5 Europe Human Single-Cell Multi-Omics Revenue Share by Application (2021-2032)
  10. 9.6 Europe Human Single-Cell Multi-Omics Revenue by Country
  11. 9.6.1 Europe Human Single-Cell Multi-Omics Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Human Single-Cell Multi-Omics Revenue by Country (2021-2026)
  13. 9.6.3 Europe Human Single-Cell Multi-Omics Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Netherlands
10 China
  1. 10.1 China Human Single-Cell Multi-Omics Revenue (2021-2032)
  2. 10.2 China Human Single-Cell Multi-Omics Revenue by Type (2021-2032)
  3. 10.2.1 China Human Single-Cell Multi-Omics Revenue by Type (2021-2026)
  4. 10.2.2 China Human Single-Cell Multi-Omics Revenue by Type (2027-2032)
  5. 10.3 China Human Single-Cell Multi-Omics Revenue Share by Type (2021-2032)
  6. 10.4 China Human Single-Cell Multi-Omics Revenue by Application (2021-2032)
  7. 10.4.1 China Human Single-Cell Multi-Omics Revenue by Application (2021-2026)
  8. 10.4.2 China Human Single-Cell Multi-Omics Revenue by Application (2027-2032)
  9. 10.5 China Human Single-Cell Multi-Omics Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Human Single-Cell Multi-Omics Revenue (2021-2032)
  2. 11.2 Asia Human Single-Cell Multi-Omics Revenue by Type (2021-2032)
  3. 11.2.1 Asia Human Single-Cell Multi-Omics Revenue by Type (2021-2026)
  4. 11.2.2 Asia Human Single-Cell Multi-Omics Revenue by Type (2027-2032)
  5. 11.3 Asia Human Single-Cell Multi-Omics Revenue Share by Type (2021-2032)
  6. 11.4 Asia Human Single-Cell Multi-Omics Revenue by Application (2021-2032)
  7. 11.4.1 Asia Human Single-Cell Multi-Omics Revenue by Application (2021-2026)
  8. 11.4.2 Asia Human Single-Cell Multi-Omics Revenue by Application (2027-2032)
  9. 11.5 Asia Human Single-Cell Multi-Omics Revenue Share by Application (2021-2032)
  10. 11.6 Asia Human Single-Cell Multi-Omics Revenue by Country
  11. 11.6.1 Asia Human Single-Cell Multi-Omics Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Human Single-Cell Multi-Omics Revenue by Country (2021-2026)
  13. 11.6.3 Asia Human Single-Cell Multi-Omics Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Human Single-Cell Multi-Omics Revenue (2021-2032)
  2. 12.2 SAMEA Human Single-Cell Multi-Omics Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Human Single-Cell Multi-Omics Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Human Single-Cell Multi-Omics Revenue by Type (2027-2032)
  5. 12.3 SAMEA Human Single-Cell Multi-Omics Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Human Single-Cell Multi-Omics Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Human Single-Cell Multi-Omics Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Human Single-Cell Multi-Omics Revenue by Application (2027-2032)
  9. 12.5 SAMEA Human Single-Cell Multi-Omics Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Human Single-Cell Multi-Omics Revenue by Country
  11. 12.6.1 SAMEA Human Single-Cell Multi-Omics Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Human Single-Cell Multi-Omics Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Human Single-Cell Multi-Omics Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst